ICYMI: CIVICASCRIPT BRINGS FIRST GENERIC DRUG TO MARKET TO PROVIDE MORE AFFORDABLE ALTERNATIVE TO HIGH-PRICED BIG PHARMA PRODUCTS
Private Sector and Non-Profit Partners Introduce Cancer Treatment That Can… Read More
Private Sector and Non-Profit Partners Introduce Cancer Treatment That Can… Read More
Big Pharma Giants All Top Analysts’ Expectations as Pharmaceutical Industry… Read More
Bipartisan Interagency Patent Coordination and Improvement Act of 2022 Will… Read More
Big Pharma Kicks Off Q2 Earnings Calls After More than 100 Price Hikes to… Read More
Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma… Read More
Joint Effort Aims to Curb Anti-Competitive Tactics Used by Brand Name Drug… Read More
Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While… Read More
PhRMA Ads Falsely Claim the Industry’s Egregious Pricing Practices Don’t… Read More
Committee Report Shows How Brand Name Drug Company Further Juiced Profits on… Read More
Congress Should Swiftly Advance Solutions to Deliver Relief for Millions of… Read More
Lawmakers Can Highlight Tactics Designed to Block More Affordable Alternatives… Read More
Big Pharma Trots Out Tired, Dishonest Arguments Designed to Evade… Read More